Skip to main content

Hypoxanthine-guanine phosphoribosyltransferase (hgprt)

Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) is a purine salvage enzyme that uses PRPP to convert hypoxanthine into IMP and guanine into GMP. In Biological Chemistry I, it shows how cells recycle bases instead of rebuilding them.

Last updated July 2026•Fiveable Content Team

What is hypoxanthine-guanine phosphoribosyltransferase (hgprt)?

Hypoxanthine-guanine phosphoribosyltransferase, or HGPRT, is the enzyme that salvages two purine bases, hypoxanthine and guanine, and turns them back into nucleotides. In Biological Chemistry I, you meet it in nucleotide metabolism as a shortcut that keeps purine pools stocked without having to make everything from scratch.

The reaction is a transfer reaction. HGPRT takes the ribose-phosphate group from PRPP, which stands for 5-phosphoribosyl-1-pyrophosphate, and attaches it to the free base. Hypoxanthine becomes IMP, and guanine becomes GMP. That means HGPRT does not build a new ring system, it recycles a base that already exists and makes it useful again.

This matters because purine nucleotides are constantly being used and broken down. DNA synthesis, RNA synthesis, energy transfer, and signaling all depend on a steady supply of nucleotides. Salvage pathways like this one save energy compared with de novo synthesis, and they also help cells keep the balance between different nucleotide types.

HGPRT is especially active in tissues that need tight control over nucleotide levels. When the enzyme works normally, hypoxanthine and guanine are pulled back into the nucleotide pool instead of being lost as waste products. That makes the pathway efficient and keeps the cell from overproducing the more expensive de novo purines.

A useful way to think about HGPRT is as a recycling enzyme with a very specific job. It does not salvage adenine, it does not make pyrimidines, and it does not directly build nucleic acids. It takes free purine bases, combines them with PRPP, and returns them as IMP or GMP, which can then feed into the rest of purine metabolism.

Why hypoxanthine-guanine phosphoribosyltransferase (hgprt) matters in Biological Chemistry I

HGPRT is one of the cleanest examples of how salvage pathways cut down the cost of nucleotide metabolism. If you understand this enzyme, you can explain why cells do not rely only on de novo synthesis and why PRPP shows up as such a central activated ribose donor.

It also helps you track cause and effect in purine balance. When HGPRT activity drops, hypoxanthine and guanine are no longer recycled efficiently, so the cell leans harder on de novo purine synthesis. That shift can raise uric acid production and disturb overall nucleotide homeostasis.

This term also connects biochemical mechanism to disease. HGPRT deficiency is tied to Lesch-Nyhan syndrome, which gives the pathway real clinical meaning instead of leaving it as a memorized reaction. In a Biochemical Chemistry I class, that link shows up when you are asked to connect an enzyme defect to a metabolic outcome, not just name the enzyme.

Keep studying Biological Chemistry I Unit 11

Official unit cheatsheet

open one-pager

How hypoxanthine-guanine phosphoribosyltransferase (hgprt) connects across the course

Purine Salvage Pathway

HGPRT is one of the main enzymes in the purine salvage pathway. The pathway recycles free purine bases instead of forcing the cell to synthesize new ones, which saves energy and helps maintain nucleotide balance. If you know the salvage pathway, HGPRT is the step that makes hypoxanthine and guanine reusable.

5-Phosphoribosyl-1-pyrophosphate (PRPP)

PRPP is the activated ribose-phosphate donor that HGPRT uses in its reaction. Without PRPP, HGPRT has nothing to transfer onto the free base. In problem sets, PRPP often shows up as the molecule that connects salvage, de novo synthesis, and the cell’s larger nucleotide budget.

Lesch-Nyhan Syndrome

HGPRT deficiency is the biochemical defect behind Lesch-Nyhan syndrome. That connection turns a pathway question into a disease question, because the loss of salvage changes purine handling and can lead to severe neurological symptoms along with abnormal uric acid buildup.

de novo synthesis

De novo synthesis and salvage are the two main ways cells get nucleotides. When HGPRT is working, the cell can rely more on salvage and less on making purines from scratch. If HGPRT is missing or weak, de novo synthesis usually has to pick up the slack, which changes energy demand and metabolite flow.

Is hypoxanthine-guanine phosphoribosyltransferase (hgprt) on the Biological Chemistry I exam?

A quiz question may give you a reaction scheme and ask which enzyme converts hypoxanthine to IMP or guanine to GMP. That is HGPRT. In a metabolism problem, you might need to trace what happens when HGPRT is deficient, then explain why PRPP builds up, why purine salvage falls, and how that shifts the cell toward de novo synthesis.

You may also see HGPRT inside a disease prompt. The move is to connect the enzyme defect to a metabolic phenotype, not just recite the name. If the question asks for pathway identification, look for the combination of a free purine base plus PRPP and the products IMP or GMP.

Hypoxanthine-guanine phosphoribosyltransferase (hgprt) vs adenine phosphoribosyltransferase deficiency

These are both salvage-pathway topics, but they are not the same enzyme. HGPRT salvages hypoxanthine and guanine, while adenine phosphoribosyltransferase handles adenine. If a problem mentions hypoxanthine or guanine becoming IMP or GMP, that points to HGPRT, not the adenine enzyme.

Key things to remember about hypoxanthine-guanine phosphoribosyltransferase (hgprt)

  • HGPRT is a purine salvage enzyme that recycles hypoxanthine and guanine back into nucleotides.

  • It uses PRPP as the ribose-phosphate donor and produces IMP from hypoxanthine and GMP from guanine.

  • The enzyme saves energy by letting the cell reuse bases instead of making every purine from scratch.

  • HGPRT deficiency is the classic biochemical link to Lesch-Nyhan syndrome.

  • If you see a reaction involving a free purine base plus PRPP, think salvage pathway and HGPRT.

Frequently asked questions about hypoxanthine-guanine phosphoribosyltransferase (hgprt)

What is hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in Biological Chemistry I?

HGPRT is a purine salvage enzyme that converts hypoxanthine into IMP and guanine into GMP using PRPP. In Biochemical Chemistry I, it shows how cells recycle nucleic acid breakdown products instead of wasting them.

What reaction does HGPRT catalyze?

HGPRT transfers a phosphoribosyl group from PRPP onto hypoxanthine or guanine. That makes IMP from hypoxanthine and GMP from guanine. The reaction is part of nucleotide salvage, not de novo purine synthesis.

How is HGPRT related to Lesch-Nyhan syndrome?

A lack of HGPRT activity causes impaired purine salvage and can lead to Lesch-Nyhan syndrome. The metabolic imbalance raises uric acid production and creates major neurological and behavioral symptoms.

Is HGPRT the same as adenosine kinase or adenine phosphoribosyltransferase deficiency?

No. HGPRT handles hypoxanthine and guanine, while adenine phosphoribosyltransferase handles adenine and adenosine kinase phosphorylates adenosine. These enzymes are related because they all affect nucleotide pools, but they act on different substrates.